FKBP12 is not required for the modulation of transforming growth factor β receptor I signaling activity in embryonic fibroblasts and thymocytes

Cell Growth and Differentiation

Volumn 9, Issue 3, 1998, Pages 223-228

  Bassing, Craig H ^a,c   Shou, Weinian ^b   Muir, Scott ^a   Heitman, Joseph ^a   Matzuk, Martin M ^b   Wang, Xiao Fan ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; FIBROBLAST; GROWTH REGULATION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; THYMOCYTE; TRANSCRIPTION REGULATION;

ACTIVIN RECEPTORS, TYPE I; ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; DNA-BINDING PROTEINS; FIBROBLASTS; GENE EXPRESSION REGULATION; HEAT-SHOCK PROTEINS; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, KNOCKOUT; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; SIGNAL TRANSDUCTION; TACROLIMUS; TACROLIMUS BINDING PROTEINS; THYMUS GLAND; TRANSFORMING GROWTH FACTOR BETA;

MUSTELA VISON;

EID: 0031879342     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Roberts, A. B., and Sporn, M. B. The transforming growth factor-β. In: M. B. Sporn and A. B. Roberts (eds.), Peptide Growth Factors and Their Receptors, Part 1, pp. 419-472. Heidelberg, Germany: Springer-Verlag, 1990.
2. Lyons, R. M., and Moses, H. L. Transforming growth factors and the regulation of cell proliferation. Eur. J. Biochem., 187: 467-473, 1990.
3. Massague, J. The transforming growth factor-β family. Annu. Rev. Cell Biol., 6: 597-641, 1990.
4. Boyd, F., and Massague, J. Transforming growth factor-β inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor. J. Biol. Chem., 264: 2272-2278, 1989.
5. Laiho, M., Weis, F. M. B., and Massague, J. Concomitant loss of transforming growth factor (TGF)-β receptor type I and II in TGF-β-resistant cell mutants implicates both receptor types in signal transduction. J. Biol. Chem., 265: 18518-18524, 1990.
6. Laiho, M., Weis, F. M. B., Boyd, F. T., Ignotz, R. A., and Massague, J. Responsiveness to transforming growth factor-β (TGF-β) restored by genetic complementation between cells defective in TGF-β receptors I and II. J. Biol. Chem., 266: 9108-9112, 1991.
7. Lin, H. Y., Wang, X-F., Ng-Eaton, E., Weinberg, R. A., and Lodish, H. F. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell, 68: 775-785, 1992.
8. Wrana, J. L., Attisano, L., Carcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X-F., and Massague, J. TGF-β signals through a heteromeric protein kinase receptor complex. Cell, 71: 1003-1014, 1992.
9. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massague, J. Mechanism of activation of the TGF-β receptor. Nature (Lond.), 370: 341-347, 1994.
10. Franzen, P., ten Dijke, P., Ichijo, H., Yamashita, H., Schulz, P., Heldin, C-H., and Miyazono, K. Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell, 75: 681-692, 1993.
11. Bassing, C. H., Yingling, J. M., Howe, D. J., Wang, T., He, W. W., Gustafson, M. L., Shah, P., Donahoe, P. K., and Wang, X-F. A transforming growth factor β type I receptor that signals to activate gene expression. Science (Washington DC), 263: 87-89, 1994.
12. Moustakas, A., Lin, H. Y., Henis, Y. I., Plamondon, J., O'Connor-McCourt, M. D., and Lodish, H. The transforming growth factor β receptors I, II and III form hetero-oligomeric complexes in the presence of ligand. J. Biol. Chem., 268: 22215-22218, 1993.
13. Yamashita, H., Dijke, P. T., Franzen, P., Miyazono, K., and Heldin, C-H. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β. J. Biol. Chem., 269: 20172-20178, 1994.
14. Wieser, R., Wrana, J. L., and Massague, J. GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J., 14: 2199-2208, 1995.
15. Massague, J. TGF-β signaling: receptors, transducers, and Mad proteins. Cell, 85: 947-950, 1996.
16. Derynck, R., and Zhang, Y. Intracellular signaling: the Mad way to do it. Curr. Biol., 6: 1226-1229, 1996.
17. Chen, X., Rubock, M. J., and Whitman, M. Atranscriptional partner for MAD proteins in TGF-β signalling. Nature (Lond.), 383: 691-696, 1996.
18. Chen, X., Weisberg, E., Fridmacher, V., Watanabe, M., and Whitman, M. Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature (Lond.), 389: 85-89, 1997.
19. Kim, J., Johnson, K., Chen, H. J., Carroll, S., and Laughon, A. Drosophila MAD binds to DNA and directly mediates activation of vestigial by decapentaplegic. Nature (Lond.), 388: 304-308, 1997.
20. Yingling, J. M., Datto, M. B., Wong, C., Frederick, J. P., Liberati, N. T., and Wang, X-F. Tumor suppressor Smad4 is a transforming growth factor β-inducible DNA-binding protein. Mol. Cell. Biol., 17: 7019-7028, 1997.
21. Wang, T., Donahoe, P. K., and Zervos, A. Specific interaction of type I receptors of the TGF-β family with the immunophilin FKBP-12. Science (Washington DC), 265: 674-676, 1994.
22. Kawabata, M., Imamura, T., Miyazono, K., Engel, M. E., and Moses, H. L. Interaction of the transforming growth factor-β type I receptor with farnesyl-protein transferase-α. J. Biol. Chem., 270: 29628-29631, 1995.
23. Ventura, F., Liu, F., Doody, J., and Massague, J. Interaction of transforming growth factor-β receptor I with farnesyl-protein transferase-α in yeast and mammalian cells. J. Biol. Chem., 271: 13931-13934, 1996.
24. RAS farnesyItransferase α subunit in TGF-β and activin signaling. Science (Washington DC), 271: 1120-1122, 1996.
25. Chamg, M-J., Kinnunen, P., Hawker, J., Brand, T., and Schneider, M. D. FKBP-12 recognition is dispensable for signal generation by type I transforming growth factor-β receptors. J. Biol. Chem., 271:22941-22944, 1996.
26. Okadome, T., Oeda, E., Saitoh, M., Ichijo, H., Moses, H. L., Miyazono, K., and Kawabata, M. Characterization of the interaction of FKBP12 with the transforming growth factor-β type I receptor in vivo. J. Biol. Chem., 271: 21687-21690, 1996.
27. Wang, T., Li, B-Y., Danielson, P. D., Shah, P. C., Rockwell, S., Lechleider, R. J., Martin, J., Manganaro, T., and Donahoe, P. K. The immunophilin FKBP12 functions as a common inhibitor of the TGF-β family type I receptors. Cell, 86: 435-444, 1996.
28. Heitman, J., Movva, N. R., and Hall, M. N. Proline isomerases at the crossroads of protein folding, signal transduction, and immunosuppression. New Biol., 4: 448-460, 1992.
29. Fruman, D. A., Burakoff, S. L., and Bierer, B. E. Immunophilins in protein folding and immunosauppression, FASEB J., 8: 391-400, 1994.
30. Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., and Schreiber, S. L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell, 68: 807-815, 1991.
31. Liu, J., Albers, M. W., Wandless, T. J., Alberg, D. G., Beishaw, P. J., Cohen, P., Mackintosh, C., Klee, C. B., and Schreiber, S. L. Inhibition of T-cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry, 31: 3896-3901, 1992.
32. Clipstone, N. A., and Crabtree, G. R. Identification of calcineurin as a key signaling enzyme in T-lymphocyte activation. Nature (Lond.), 357: 695-697, 1992.
33. Heitman, J., Mowa, N. R., and Hall, M. N. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science (Washington DC), 253:905-909, 1991.
34. 1 progression. Cell, 73: 585-596, 1993.
35. 1- arresting rapamycin-receptor complex. Nature (Lond.), 369: 756-758, 1994.
36. Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., and Snyder, S. H. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell, 78: 35-43, 1994.
37. Brown, E. J., Beal, P. A., Keith, C. T., Chen, J., Bumshin, T., and Schreiber, S. L. Control of p70 S6 kinase by kinase activity of FRAP in vivo. Nature (Lond.), 377: 441-446, 1995.
38. Zheng, X-F., Fiorentino, D., Chen, J., Crabtree, G. R., and Schreiber, S. L. TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin. Cell, 82: 121-130, 1995.
39. Alarcon, C. M., Cardenas, M. E., and Heitman, J. Mammalian RAFT1 kinase domain provides rapamycin-sensitive TOR function in yeast. Genes Dev., 10: 279-288, 1996.
40. Jayaraman, T., Brillantes, A. M., Timerman, A. P., Fleischer, S., Tempst, P., and Marks, A. R. FK506 binding protein associated with the calcium release channel (ryanodine receptor). J. Biol. Chem., 267: 9474-9477, 1992.
41. Cameron, A. M., Steiner, J. P., Sabatini, D. M., Kaplin, A. I., Walensky, L. D., and Snyder, S. H. Immunophilin FK506 binding protein associated with inositol 1,4,5-triphosphate receptor modulates calcium flux. Proc. Natl. Acad. Sci. USA, 92: 1784-1788, 1995.
42. Shou, W., Aghdasi, B., Armstrong, D. L., Guo, Q., Bao, S., Chamg, M-J., Mathews, L. M., Schneider, M. D., Hamilton, S. L., and Matzuk, M. M. Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12. Nature (Lond.), 391: 489-492, 1998.
43. Chen, Y-G., Liu, F., and Massague, J. Mechanism of TGF-β receptor inhibition by FKBP12. EMBO J., 16: 3866-3876, 1997.
44. Synder, S. H., and Sabatini, D. M. Immunophilins and the nervous system. Nat. Med., 1: 32-37, 1995.
45. Baughman, G., Wiederrecht, G. J., Campbell, N. F., Martin, M. M., and Bourgeois, S. FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition. Mol. Cell. Biol., 15: 4395-4402, 1995.
46. Arakawa, H., Nagase, H., Hayashi, N., Fujiwara, T., Ogawa, M., Shin, S., and Nakamaru, Y. Molecular cloning and expression of a novel human gene that is highly homologous to human FK506-binding protein 12 kDa (hFKBP-12) and characterization of two alternatively spliced transcripts. Biochem. Biophys. Res. Commun., 200: 836-843, 1994.
47. Lam, E., Martin, M. M., Timerman, A. P., Sabers, C., Fleischer, S., Lukas, T., Abraham, R. T., O'Keefe, S. J., O'Neill, E. A., and Wiederrecht, G. J. A novel FK506 binding protein can mediate the immunosuppressive effects of FK506 and is associated with the cardiac ryanodine receptor, J. Biol. Chem., 270: 26511-26522, 1995.